Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
about
Synergistic effects of green tea polyphenols and alphacalcidol on chronic inflammation-induced bone loss in female ratsDose effect of tumor necrosis factor-alpha on in vitro osteogenic differentiation of mesenchymal stem cells on biodegradable polymeric microfiber scaffolds.Modulation of the inflammatory response for enhanced bone tissue regenerationKruppel-like factor 4 attenuates osteoblast formation, function, and cross talk with osteoclastsTNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells.The biology of fracture healing.Infection, inflammation, and bone regeneration: a paradoxical relationshipSodium-dependent phosphate transporters in osteoclast differentiation and function.Harnessing and modulating inflammation in strategies for bone regeneration.Student Award for Outstanding Research Winner in the Ph.D. Category for the 9th World Biomaterials Congress, Chengdu, China, June 1-5, 2012: The interplay of bone-like extracellular matrix and TNF-α signaling on in vitro osteogenic differentiation oSoy isoflavones avert chronic inflammation-induced bone loss and vascular disease.The treatment of nonunions with application of BMP-7 increases the expression pattern for angiogenic and inflammable cytokines: a matched pair analysis.Effect of temporally patterned TNF-α delivery on in vitro osteogenic differentiation of mesenchymal stem cells cultured on biodegradable polymer scaffolds.Implanted bisphosphonates in bone cement affect bone markers in rat serum.Extracellular Iron is a Modulator of the Differentiation of Osteoclast Lineage Cells.Glutamate Receptor Agonists and Glutamate Transporter Antagonists Regulate Differentiation of Osteoblast Lineage Cells.Elevated FGF23 Levels in Mice Lacking the Thiazide-Sensitive NaCl cotransporter (NCC).The Effect of TAK-778 on Gene Expression of Osteoblastic Cells Is Mediated Through Estrogen Receptor
P2860
Q28576330-5F341863-6991-4227-B870-54AFC12F92FEQ33621102-3BC798F1-AF9F-4DDF-BF8A-4FDB65785F43Q34234144-4E43877C-5FF0-43BD-9777-935A079A0E22Q34409480-3B801520-087C-4B27-8055-D33A0EDD7BCFQ34534156-E075C9FD-F76C-43E0-8820-33CF715FFF72Q35017085-9192A773-1764-4C67-8BE8-75FF7645CD10Q35205143-5263AC40-B1FF-4C35-B28E-6410BEE04105Q35536195-0060B4A8-5C3F-477A-AFCF-FA19F1208E5FQ35570026-13D673BA-14D5-42B4-918C-3CE9938DE901Q35854657-AF9AFA93-F7E4-4672-8118-D992BFDB3921Q36082676-ADD42756-5CD1-44A5-9511-2D3049C959F9Q36153143-8D7EA2C7-FF42-480D-8C6E-4603E633E21CQ37171375-7FA08E68-507C-48AE-883F-A1F85E3CA2C3Q39973429-15E3F00B-4851-48DD-8D75-CAA82E6E2C1CQ40265605-52B6690B-A997-446B-9A75-05CB003734DBQ53136788-DE5DEDD2-5CB8-48E4-9EC9-741B8958D9EBQ55344755-4DC67A58-7417-4BD2-B476-34BAE2B99E66Q58286194-4E9D8683-E3CA-49BB-B356-8689EA6B0B8C
P2860
Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Tumor necrosis factor-alpha: a ...... osteoclast formation in vitro.
@ast
Tumor necrosis factor-alpha: a ...... osteoclast formation in vitro.
@en
type
label
Tumor necrosis factor-alpha: a ...... osteoclast formation in vitro.
@ast
Tumor necrosis factor-alpha: a ...... osteoclast formation in vitro.
@en
prefLabel
Tumor necrosis factor-alpha: a ...... osteoclast formation in vitro.
@ast
Tumor necrosis factor-alpha: a ...... osteoclast formation in vitro.
@en
P2093
P1433
P1476
Tumor necrosis factor-alpha: a ...... osteoclast formation in vitro.
@en
P2093
Antoinette Wetterwald
Jeannette Portenier
Renate Balga
Silvia Dolder
Willy Hofstetter
P304
P356
10.1016/J.BONE.2006.02.056
P577
2006-03-31T00:00:00Z